How much is Ambagon Therapeutics worth in 2026?

Ambagon Therapeutics has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has Ambagon Therapeutics raised?

Ambagon Therapeutics has raised $108.0M in total funding across 1 funding rounds.

Ambagon Therapeutics

Drug DiscoveryWebsite

Ambagon Therapeutics valuation and funding history | Last updated: February 7, 2025 | 1 funding rounds

Current Valuation

N/A

As of February 7, 2025

Total Funding Raised

$108.0M

Across 1 round

Last Round

Early Stage VC

$5.0M

Last Funding

Feb 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 5, 2022	Early Stage VC (Series A)	$85.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Ambagon Therapeutics is currently valued at N/A as of February 7, 2025. The company has raised a total of $108.0M in funding across 1 funding round.

Track Ambagon Therapeutics Valuation Updates

Get notified when Ambagon Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Ambagon Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Ambagon Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Ambagon Therapeutics Worth in 2026?

Ambagon Therapeutics is a leading private company in the Drug Discovery sector. Track Ambagon Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Ambagon Therapeutics Valuation is Determined

Private company valuations like Ambagon Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.